Tech Company Financing Transactions
Volition Funding Round
On 3/31/2026, Volition raised $2.3 million in investment from Namur Invest and Wallonie Entreprendre.
Transaction Overview
Company Name
Announced On
3/31/2026
Transaction Type
Venture Equity
Amount
$2,300,000
Round
Undisclosed
Investors
Namur Invest (Nicolas Delahaye)
Wallonie Entreprendre (Géry Lefebvre)
Proceeds Purpose
Volition will use the proceeds from the financing for ongoing development of its Nu.Q® product portfolio, including taking forward its regulatory transition program for Nu.Q® NETs (from IVDD to IVDR), the continued research and development of a Lateral Flow product, specifically to enable access to its Nu.Q® NETs product in Low Income Countries and more.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
1489 West Warm Springs Road 110
Henderson, NV 89014
USA
Henderson, NV 89014
USA
Phone
Undisclosed
Website
Email Address
Overview
Volition is a multi-national epigenetic company focused on advancing the science of epigenetics. We are dedicated to saving lives and improving outcomes for people and animals with life-altering diseases through earlier detection, as well as disease and treatment monitoring. Through our subsidiaries, we are developing and commercializing simple, easy to use, cost-effective blood tests to help diagnose and monitor a range of diseases, including some cancers and diseases associated with NETosis, such as sepsis.
Management Team
Title
Name
Email & Social
Browse more venture capital transactions:
Prev: 3/31/2026: ContractorHUB venture capital transaction
Next: 3/31/2026: Monarch Quantum venture capital transaction
Share this article
News on VC Transactions
We do our best to record every notable VC transaction. VC investment data records on this site are derived from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs








